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Background. Acute and chronic pain is common in hospitalized demented elderly people, yet there are limited data
about the performance of pain assessment tools in this population. The aim of this study was to evaluate the feasibility and
reliability of four pain self-assessment scales in this population and compare their performance to an observational pain
rating scale.
Methods. Our prospective clinical study was conducted in an acute-care and intermediate-care geriatric hospital on 160
consecutive inpatient referrals to the dementia consultation who met Diagnostic and Statistical Manual of Mental
Disorders–IV criteria for dementia. Exclusion criteria were delirium, terminal care, and severe sensory impairment. Four
unidimensional self-assessment tools—the verbal, horizontal visual, vertical visual, and faces pain scales—were
administered in randomized order to mild, moderate, and severely demented patients. An observational pain rating scale
was independently completed by the nursing team.
Results. Only 12% of the 160 patients (mean age 85 years, 71% women) understood no scale. Respectively, 97%,
90%, and 40% of patients with mild, moderate, and severe dementia understood at least one scale ( p , .05). There was
a nonsignificant trend toward poorer comprehension of the faces scale. Test–retest reliability was high for all four self-
assessment scales, and the correlation between these scales was very strong (Spearman’s rs ¼ 0.81–0.95; p , .001).
Observational rating correlated moderately with self-assessment and tended to underestimate pain intensity (rs ¼ 0.31–
0.40; p , .05).
Conclusions. Self-assessment pain scales can be used reliably in the vast majority of older hospitalized patients with
mild to moderate dementia and in nearly half of those with severe dementia. Observational pain rating scales correlate only
moderately with self-assessment and should be reserved for those few patients who have demonstrated that they cannot
complete a self-assessment.
PERSISTENT pain is a major concern in elderly patients.It is highly prevalent among nursing home residents,
and may occur in 25%–50% of community-dwelling older
people (1–7). Its consequences include impaired ambula-
tion, depression, anxiety, decreased socialization, sleep
disturbance, increased health-care utilization, and higher
health-related costs (8). Pain assessment remains difficult in
frail elderly persons, and undertreatment is not uncommon
(9,10). This may be related in part to the high prevalence
of dementia in this population (11–13). Dementia is an
important barrier to pain assessment, and several studies
(14–16) have demonstrated that cognitively impaired
patients receive fewer analgesics than do cognitively intact
patients with similar pathology.
Self-assessment scales based on the patient’s own report
are the current standard in pain measurement. Several studies
(6,14,17–19) suggest that they can be used in demented
populations and can improve pain detection. However, their
reliability in cognitively impaired populations has not been
well tested, and their application may be impossible in more
severely demented patients. To circumvent this issue, several
scales have been developed to allow observational rating of
a patient’s pain (20,21), yet it is unclear how well these scales
correlate with the patient’s self-assessment and at what level
of cognitive impairment they should be preferred to self-
assessment scales. To address these issues, we determined the
feasibility and reliability of four self-assessment scales in
demented hospitalized elderly people, according to the
severity of their cognitive deficits. Furthermore, we compared
pain scores obtained by self-assessment and by observational
rating in this population. The purpose of this study was to help
define the best choice among currently available pain
assessment scales for individuals with dementia.
METHODS
All consecutive French-speaking hospitalized patients
who were referred to the inpatient dementia consultation of
the Geneva University Geriatric Hospital between October
2001 and April 2002 and who met Diagnostic and Statistical
Manual of Mental Disorders–IV (DSM-IV) criteria for
dementia were eligible for the study. Exclusion criteria were
delirium, end-of-life care, and severe sensory impairment.
Eight cases were excluded altogether (5 with delirium who
left the hospital after the delirium subsided but before they
could be contacted again to participate in the study and 3
who refused consent). A total of 160 patients participated in
the study, and all underwent a complete neuropsychological
evaluation (which is described in detail elsewhere) and
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appropriate laboratory testing, including neuroimaging (22).
Alzheimer’s disease and vascular dementia were diagnosed
according to National Institute of Neurological and Com-
municative Disorders and Stroke and the Alzheimer’s
Disease and Related Disorders Association (NINCDS-
ADRDA) and National Institute of Neurological Disorders
and Stroke–Association Internationale pour la Recherche et
l’Enseignment en Neurosciences (NINDS-AIREN) criteria,
respectively (23,24). A validated scale, the clinical dementia
rating (CDR) scale, was used in all cases to assess the
severity of dementia (25). The CDR assigns cognitive
function to five levels defined as no dementia (CDR ¼ 0),
questionable dementia (CDR¼ 0.5), mild dementia (CDR¼
1), moderate dementia (CDR ¼ 2), and severe dementia
(CDR ¼ 3). Dementia severity and exclusion criteria were
confirmed by a senior physician who is highly experienced in
the field of dementia and cognitive impairment. All patients
were asked if they experienced any pain at the time of
the assessment. Other collected data included admission
diagnosis, the number of comorbidities measured by the
Charlson’s comorbidities score (26), and use of analgesics.
The following four different unidimensional pain self-
assessment scales were presented to each patient in a random
order. The horizontal visual analog scale (HVAS) consists
of a 10-cm line anchored by two extremes of pain: no pain
and extreme pain. Patients were asked to position a sliding
vertical marker to indicate the level of pain they were
currently experiencing; pain severity is measured as the
distance (in cm) between the zero position and the marked
spot (27,28). The vertical visual analog scale (VVAS) is
similar to the prior scale but is presented vertically, and the
line is replaced by a red triangle with its summit facing
downward (no pain ¼ 0) and its base at the top (maximum
pain ¼ 10) (29,30). The faces pain scale (FPS) consists of
a line drawing of seven faces which express increasing pain
(no pain ¼ 0, maximum pain ¼ 6) (31). The 6-point verbal
rating scale (VRS) consists of a list of adjectives which
describe different levels of pain. Patients were asked to point
to the adjective that best describes their current pain.
We used a French set of adjectives which is included in
the validated French version of the McGill questionnaire
(32). Examination was completed with the examiners in a
quiet room with the patient in a sitting position. Each scale
was explained to the patient using a standard text, and
standardized distraction material was used between each
presentation. Patients who could demonstrate comprehen-
sion of a scale were then asked to indicate their current level
of pain. The entire procedure was repeated 30 minutes later
either by the same investigator (50% of the cases) or by
a different examiner who was blinded to the first assessment.
Patients were considered to have understood a scale if, on
both occasions, they were able to explain its use and could
correctly indicate which position corresponded to no pain at
all and which position corresponded to the most severe pain.
On each occasion, the explanations were repeated up to three
times before patients were considered unable to comprehend
a scale. There was a high level of agreement between the two
assessments of comprehension (intrarater kappa between
0.93 and 0.97; interrater kappa between 0.86 and 0.97, de-
pending on the scale).
On the same day, an observational pain assessment scale,
Doloplus, was completed independently by the nursing staff
in charge of the patient. The Doloplus scale was developed to
assess pain in older people with communication disorders. It
includes five somatic items (somatic complaints, protective
body posture adopted at rest, protection of sore areas, facial
expression and gaze, and sleep pattern), two psychomotor
items (based on observation of washing and/or dressing and
mobility), and three psychosocial items (communication,
social interaction, and behavior). Each item is scored from
0 to 3 yielding an overall score between 0 and 30. A score
5 is considered indicative of pain (20,21,33). The study
investigators and the nursing staff were blinded to each
other’s assessments.
To compare patient characteristics among dementia severity
levels, categorical variables were evaluated by chi-square or
Fisher’s exact test as extended by Mehta and Patel (34) when
appropriate, and analysis of variance was used for continuous
variables. The intraclass correlation coefficient (ICC) was
used to measure interrater and intrarater reliability. Spear-
man’s rho correlation coefficient was chosen to assess the
strength of the association between pain intensities measured
by the different scales. After converting all scales to percent
scores (no pain¼0%; maximum pain¼100%), the Wilcoxon
matched-pairs signed-ranks test was used to evaluate whether
the observational scale under- or overestimated pain compared
to self-assessments. All analyses were performed with the
Stata 7.0 statistical package (STATA Corp., College Station,
TX), with the exception of reliability analysis (ICC with 95%
confidence interval, test of significance for comparing ICC to
0.999) which was carried out with SPSS release 11.0
(Chicago, IL). The study protocol was approved by the local
ethics committee, and all study participants or appropriate
surrogates gave written informed consent.
RESULTS
The main reasons for admission in the studied popula-
tion were falls (n¼ 50; 31%), altered mental status (n¼ 33;
21%), heart failure or myocardial infarction (n¼ 31; 19%),
infectious disease (n ¼ 22; 14%), fracture (n ¼ 19; 12%),
and thromboembolism (n ¼ 5; 3%). The most common
comorbidities were depression (n¼ 56; 35%), hypertension
(n ¼ 42; 26%), cardiac disease (n ¼ 42; 26%), and chronic
pulmonary disease (n¼ 10; 6%). Other characteristics of the
160 patients are described in Table 1. Age, sex distribution,
type of dementia, and Charlson’s comorbidity score were not
significantly different in individuals with mild, moderate, or
severe dementia (Table 1). Nearly half the patients (47%)
reported that they experienced pain in response to a direct
question, and 24% of such cases were receiving no
analgesics. Pain was mainly musculoskeletal in origin.
There was no significant effect of dementia severity on the
proportion of patients reporting pain or receiving analgesic
therapy (Fisher’s exact test; p . .05) (Table 2). Among
patients who reported pain and demonstrated the capacity to
use self-assessment scales reliably, pain intensities measured
by the VRS, HVAS, VVAS, and FPS were, respectively, 3.0
[1.5], 5.0 [2.0], 5.0 [1.0], and 3.0 [2.0]; (median, interquartile
range) for mildly demented patients and 3.0 [3.0], 4.0 [5.0],
5.0 [5.0], and 3.0 [3.0] (median, interquartile range) for
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moderately demented patients. None of the severely de-
mented patients who could demonstrate appropriate use of
the self-assessment scales reported experiencing any pain.
Among all patients reporting pain, intensity measured by the
observational rating scale was 5.0 [6.0], 4.5 [7.0], and 13
[8.0] (median, interquartile range) for mild, moderate, and
severely demented patients, respectively. Comprehension
rates were generally similar for all four self-assessment
scales although there was a nonsignificant trend toward
poorer comprehension of the faces scale and greater
comprehension of the HVAS in patients with mild and
moderate dementia. There was also a trend toward greater
comprehension of the VRS in the severe dementia group
(Table 3). The ability to comprehend and use a self-
assessment scale was not related to dementia type; however,
it was closely related to dementia severity. Respectively,
97%, 90%, and 40% of patients with mild (62/64 cases),
moderate (73/81 cases), and severe dementia (6/15 cases)
understood at least one scale ( p , .05) (Table 4). Only 12%
of the patients understood no scale at all.
The reliability of the four self-assessment scales was
substantial (0.60 , ICC , 0.8) to almost perfect (ICC .
0.8) (35). The ICCs between the first and second assess-
ments were 0.71 (FPS), 0.80 (VRS), 0.87 (VVAS), and 0.90
(HVAS) when two different raters were used and 0.94
(VVAS), 0.95 (HVAS), and 0.97 (both FPS and VRS) when
the same rater performed both assessments. In all cases the
ICCs were not statistically different from 0.999.
Correlation between the four self-assessment scales was
very strong (Spearman’s coefficient ranging from 0.81 to
0.95; p , .001) (Table 5). However, observational rating
correlated only moderately with self-assessment (Spear-
man’s coefficient raging from 0.31 to 0.40; p , .05); the
strength of the correlations did not increase in patients with
moderate to severe pain. Among the 76 cases reporting pain,
the mean scores ranged from 41% to 46% of maximum pain
levels for the four self-assessment scales and only 16% of the
maximum score for the observational rating scale (Figure 1).
It is important to note that 20% of such cases score below the
pain threshold (score , 5) on the Doloplus scale. Further-
more, 15 among the 25 cases that scored below 5 on this
scale reported feeling pain. Mean self-assessment score for
these cases was 4.9/10, 5.1/10, 3.4/6, and 3.9/7 for, respec-
tively, the HVAS, VVAS, VRS, and FPS. Among patients
reporting pain, the observational rating scale underesti-
mated severity compared to all four self-assessment scales
Table 1. Patient Characteristics
Characteristic CDR ¼ 1 (64 Cases) CDR ¼ 2 (81 Cases) CDR ¼ 3 (15 Cases) Total (160 Cases) p Value
Age, mean 6 SD 84.2 6 6.1 85.7 6 5.4 86.4 6 7.2 85.5 6 5.8 .252*
Sex, men/women 21/43 20/61 4/11 46/114 .650*
Type of dementia, n (%) .212y
Alzheimer’s disease 33 (55) 28 (35) 6 (40) 69 (43)
Mixed dementia 16 (25) 36 (44) 7 (47) 59 (37)
Vascular dementia 11 (17) 14 (17) 2 (13) 27 (16)
Other causes 2 (3) 3 (4) 0 5 (4)
Mini-Mental Status
Examination, mean 6 SD 22.8 6 5.8 16.8 6 3.6 2.1 6 4.6 17.8 6 7.4 ,.001*
Charlson’s Comorbidity
score, mean 6 SD 1.7 6 1.0 1.8 6 0.9 1.3 6 0.6 1.7 6 0.8 .156z
Notes: *Chi-square test.
yFisher’s exact test.
zOne-way analysis of variance.
CDR ¼ Clinical Dementia Rating scale; SD ¼ standard deviation.
Table 2. Patients With Painful Condition During Assessment
CDR ¼ 1 CDR ¼ 2 CDR ¼ 3 Total
N (%) N (%) N (%) N (%)
Number of patients
reporting pain 33 (52) 38 (47) 5 (33) 76 (47)
Etiology of pain
Osteoarthritis of joints 16 (48) 16 (42) 2 (40) 34 (45)
Back pain (osteoporosis
or ostheoarthritis) 9 (27) 13 (34) 1 (20) 23 (30)
Skin lesion 2 (6) 3 (8) 1 (20) 5 (6)
Other causes 6 (9) 6 (16) 1 (20) 13 (17)
Analgesics
All types 25 (76) 29 (76) 4 (75) 58 (76)
WHO 1st step* 16 (48) 18 (38) 4 (75) 38 (50)
WHO 2nd step* 6 (18) 3 (6) 1 (20) 10 (13)
WHO 3rd step* 5 (15) 2 (4) 1 (20) 8 (11)
Notes: *Patients can have two different analgesics.
CDR¼Clinical Dementia Rating scale; WHO¼World Health Organization.
Table 3. Number and Percentage of Patients Understanding Each Scale














Verbal Rating Scale (VRS) 58 (91) 59 (73) 5 (33) 122 (76)
Horizontal Visual Analong
Scale (HVAS) 62 (97) 64 (79) 4 (27) 130 (81)
Vertical Visual Analog
Scale (VVAS) 59 (92) 60 (74) 4 (27) 123 (77)
Faces Pain Scale (FPS) 57 (89) 53 (65) 4 (27) 114 (72)
Notes: For each scale, comprehension is significantly associated with the
CDR (Clinical Dementia Rating) scale.
p , .001 (Fisher’s exact test).
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(Wilcoxon’s matched-pairs signed-ranks test; p , .001 for
all four scales).
DISCUSSION
The proportion of patients reporting pain did not change
with dementia severity. Although the simple report of pain
should be interpreted with caution in demented patients, our
result does not support a putative relationship between
declining cognitive function and reduced sensitivity to pain
as suggested by some authors (19,36). Approximately one
quarter of patients reporting pain were not receiving
analgesics; this finding is consistent with other reports of
undertreatment in this population and highlights the im-
portance of appropriate pain assessment in older demented
hospitalized patients (8,14).
Although we used a particularly rigorous definition of
scale comprehension (ability to demonstrate appropriate use
on two separate occasions), we report that over 90% of
elderly hospitalized patients with mild to moderate dementia
and more than one third of those with severe dementia can
complete at least one of four pain self-assessment scales.
This finding is consistent with those of other studies
reporting a completion rate of 80% or more in cognitively
impaired elderly patients and a negative correlation between
dementia severity and the ability to understand self-
assessment scales (6,18,30). Importantly, close to half the
patients with severe dementia demonstrated appropriate use
of these scales. Thus our data do not provide any evidence
for a clear cognitive threshold below which self-assessment
scales should not be attempted.
Ability to complete an assessment does not imply
reliability. This is a key issue because unreliable measure-
ments cannot be used effectively to detect pain or, more
importantly, to measure change. The current study is, to our
knowledge, the first to demonstrate that pain self-assessment
scales possess high test–retest and interrater reliability in
a demented population. This was true for all four of the tested
unidimensional self-assessment scales. Several studies
(6,17,30) have attempted to determine the most appropriate
scale for cognitively impaired elderly, but report conflicting
results. We report a trend toward better comprehension of the
HVAS, but this is not consistent across studies. Ferrell (6)
found completion rates that vary from 44% for the HVAS
(lowest completion rate) to 65% for the present pain intensity
subscale of the McGill questionnaire, a combined word and
number scale. These findings are consistent with those of
Krulewitch and colleagues (17) who report the worst com-
pletion rate for a visual analog scale (53%) and the faces
scale (53%) compared to the pain intensity scale (62%),
a combined visual and verbal scale. However, Scherder and
Bouma (30) describe a very high completion rate for the
Colored Analog Scale (CAS) (100% in early Alzheimer’s
disease and 80% in midstage Alzheimer’s disease) and
a much lower one for the faces scale (60% and 30%,
respectively). These differences may be explained in part
by unclear definitions of comprehension, the absence of
comprehensive neuropsychological evaluations leading to
uncertainty in dementia severity assessments, and the lack
of standardized instructions prior to scale administration.
Importantly, reliability was not measured in these studies. In
our experience, all of the four tested self-assessment scales
performed similarly and were equally reliable, although
there was a trend toward poorer comprehension of the faces
scale. Although the VRS appeared to perform slightly better
among patients with severe cognitive deficits, we included
relatively few patients with severe dementia, and may not
have had sufficient power to detect differences among the
four tested scales in this particular group. Also, our study
population included only hospitalized elderly patients, a
group in which pain assessment is particularly crucial.
Further studies in nursing home and community-dwelling
elderly individuals may be needed to confirm the general-
izability of our findings to these settings.
The observational rating scale Doloplus correlated
modestly with self-assessment by the patient, and under-
estimated the level of pain. Importantly, low scores did not
rule out the presence of pain. To our knowledge, one other
study using a similarly constructed observational scale, the
Hospice Approach Discomfort Scale, also addressed this
issue and showed a poor correlation with unidimensional
self-assessment tools (18). Clinicians should not apply ob-
servational scales routinely in demented patients as many
of these are capable of reporting their own pain. Observa-
tional scales were designed, and should be reserved, for
those few patients who have demonstrated that they cannot
complete a self-assessment.
Table 5. Correlation Between Different Scales (Spearman’s Rho)
First Assessment Second Assessment
HVAS VVAS FPS VRS HVAS VVAS FPS VRS
Doloplus
(observational
rating scale) 0.35 0.40 0.34 0.31 0.36 0.39 0.35 0.34
First assessment
HVAS — 0.95 0.88 0.91 0.92 0.89 0.87 0.91
VVAS — 0.89 0.89 0.92 0.88 0.86 0.84
FPS — 0.89 0.82 0.81 0.87 0.86
VRS — 0.85 0.84 0.88 0.91
Second assessment
HVAS — 0.95 0.87 0.85
VVAS — 0.90 0.89
FPS — 0.89
VRS —
Note: HVAS ¼ Horizontal Visual Analog Scale; VVAS ¼ Vertical Visual
Analog Scale; FPS ¼ Faces Pain Scale; VRS ¼ Verbal Rating Scale.
















4 51 (80) 48 (59) 3 (19) 100 (62)
3 8 (12) 10 (12) 1 (7) 17 (13)
2 1 (2) 8 (10) 1 (7) 12 (7)
1 2 (3) 7 (9) 1 (7) 10 (6)
0 2 (3) 8 (10) 9 (60) 19 (12)
Note: CDR ¼ Clinical Dementia Rating scale.
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